Prescriptions of the oral COVID-19 treatments Paxlovid and Lagevrio have been rapidly decreasing in line with the decrease of confirmed COVID-19 cases in Korea.

On the 10th, the Korea Disease Control and Prevention Agency announced that it had prescribed Paxlovid and Lagevrio to 1,800 patients during the past week.

From 6:30 p.m. on May 3rd to 6:30 p.m. on May 9th, 1,549 courses of Paxlovid had been prescribed to patients receiving treatment from home, at residential treatment centers, and at infectious disease hospitals. In the case of Lagevrio, another oral COVID-19 treatment, 258 courses were prescribed in the same period.

Compared to two months